Fundraising FoxAcceleron
Cambridge, US · 7 known investors
Find your way into Acceleron
Sign up to see every warm intro you have to Acceleron
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Acceleron team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
A pharmaceutical company that develops medicines and vaccines for patients globally.
Founders & leadership
Investors · 7
How we know: Bessemer Venture Partners's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Foresite Capital's portfolio page · Not right? Tell us
How we know: Lightstone Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Lowercarbon Capital's portfolio page · funding news · Not right? Tell us
How we know: Sofinnova Ventures's portfolio page · Not right? Tell us
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$30.5M disclosed across 1 round · 2011
▶$30.5MraisedJan 2012 · 47 investors · BiotechnologyRule 506(b)
- STEVEN ERTELExecutive Officer
- ROBERT STEININGERExecutive Officer
- KEVIN F. MCLAUGHLINExecutive Officer
- RICHARD POPSDirector
- EDWIN M. KANIADirector
- CARL L. GORDONDirector
- JEAN GEORGEDirector
- WYLIE W. VALEDirector
- TERRANCE G. MCGUIREDirector
- JOHN KNOPFExecutive Officer, Director
- ANTHONY B EVNINDirector
- MATTHEW L. SHERMANExecutive Officer
- JOSEPH S. ZAKRZEWSKIDirector
- GEORGE GOLUMBESKIDirector
- TOM MANIATISDirector
- Offering amount
- $30.5M
- Amount sold
- $30.5M
- First sale
- Dec 2011
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Acceleron do?
- A pharmaceutical company that develops medicines and vaccines for patients globally.
- Who founded Acceleron?
- Acceleron was founded by WYLIE W. VALE, JOHN KNOPF.
- Who are Acceleron's investors?
- Acceleron's investors include Bessemer Venture Partners, Foresite Capital, Lightstone Ventures, Lowercarbon Capital, Sofinnova Ventures, Venrock, Collaborative Fund.
- How much funding has Acceleron raised?
- Acceleron has disclosed $30.5M raised across 1 round.
- Where is Acceleron headquartered?
- Acceleron is headquartered in Cambridge, US.